Unique Wealth Strategies’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,220
Closed -$890K 229
2025
Q4
$890K Buy
13,220
+4,252
+47% +$286K 0.35% 66
2025
Q3
$658K Sell
8,968
-632
-7% -$42K 0.26% 116
2025
Q2
$499K Sell
9,600
-197
-2% -$11.2K 0.21% 151
2025
Q1
$625K Sell
9,797
-235
-2% -$13.7K 0.28% 83
2024
Q4
$480K Buy
+10,032
New +$514K 0.21% 152
2024
Q3
Sell
-10,943
Closed -$445K 401
2024
Q2
$445K Hold
10,943
0.21% 153
2024
Q1
$445K Buy
+10,943
New +$410K 0.22% 153

Other funds holding HALO

Unique Wealth Strategies's HALO Position: Q1 2026 in Review

Unique Wealth Strategies sold out of Halozyme (HALO) in Q1 2026, closing a stake of 13,220 shares — an estimated $890K sold.

Unique Wealth Strategies first reported a position in HALO in Q1 2024 and held it in 7 quarters. The position peaked at $890K in Q4 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Unique Wealth Strategies reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Unique Wealth Strategies sold 13,220 Halozyme shares in Q1 2026, an estimated $890K.
  • Unique Wealth Strategies first reported a position in Halozyme in Q1 2024 and held it in 7 quarters.
  • Unique Wealth Strategies's Halozyme position peaked at $890K in Q4 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Unique Wealth Strategies's 13F filing for Q1 2026, filed 15 Jul 2026.